During wound healing, angiogenic capillary sprouts invade the fibrin/fibron
ectin-rich wound clot and within a few days organize into a microvascular n
etwork throughout the granulation tissue. As collagen accumulates in the gr
anulation tissue to produce scar, the density of blood vessels diminishes.
A dynamic interaction occurs among endothelial cells, angiogenic cytokines,
such as FGF, VEGF, TGF-beta, angiopoietin, and mast cell tryptase, and the
extracellular matrix (ECM) environment. Specific endothelial cell ECM rece
ptors are critical for these morphogenetic changes in blood vessels during
wound repair. In particular, alpha nu beta3, the integrin receptor for fibr
in and fibronectin, appears to be required for wound angiogenesis: alpha nu
beta3 is expressed on the tips of angiogenic capillary sprouts invading th
e wound clot, and functional inhibitors of alpha nu beta3 transiently inhib
it granulation tissue formation. Recent investigations have shown that the
wound ECM can regulate angiogenesis in part by modulating integrin receptor
expression. mRNA levels of alpha nu beta3 in human dermal microvascular en
dothelial cells either plated on fibronectin or overlaid by fibrin gel were
higher than in cells plated on collagen or overlaid by collagen gel. Wound
angiogenesis also appears to be regulated by endothelial cell interaction
with the specific three-dimensional ECM environment in the wound space. In
an in vitro model of human sprout angiogenesis, three-dimensional fibrin ge
l, simulating early wound clot, but not collagen gel, simulating late granu
lation tissue, supported capillary sprout formation. Understanding the mole
cular mechanisms that regulate wound angiogenesis, particularly how ECM mod
ulates ECM receptor and angiogenic factor requirements, may provide new app
roaches for treating chronic wounds.